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The original article \[[@CR1]\] contains slight errors whereby several terms in the first column of Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}, and [3](#Tab3){ref-type="table"} have an erroneous 'p' preceding them. The correct presentation of these tables can be viewed ahead.Table 1Main characteristics of the patients, pTNM-Classification 2017, 8th EditionCharacteristicsNumber of Patients (n)PercentageTumor-localization central5326.2% peripheral14973.8%Histology adenocarcinoma11757.4% SCC^a^7536.8% others125.9%GradingIn situ21% G12512.4% G29547.0% G36833.3% G4125.9%pT-categorypTis21%pT19045.1% pT1a104.9% pT1b3718.1% pT1c4321.1%pT24426.5 pT2a3919.1% pT2b157.4%pT33517.2%pT42311.3pN-category pN012661.8% pN13316.2% pN24522%pM-category pM019394.5% pM1a52.5% pM1b52.5% pM1c10.5% L-Status L05728.1% L114671.9% V-Status V016581.3% V13818.7%^a^*SCC* Squamous cell carcinomaTable 2Univariate Analysis of positive pulmonary and mediastinal lymph nodes (pN1+, pN2+)VariablespN1- (%)pN1+ (%)*P*-ValuepN2- (%)pN2+ (%)*P*-ValueSex0.1480.627 male90 (63.4)52 (36.6)112 (78.9)30 (21.1) female46 (74.2)16 (25.8)47 (75.8)15 (24.2)Age0.2980.237 ≤ 68 years68 (63)40 (37)88 (81.5)20 (81.5) \> 68 years68 (70.8)28 (29.2)71 (74.0)25 (21.2)Tumor site0.0670.783 right90 (71.4)36 (28.6)99 (78.6)27 (21.4) left46 (59)32 (41)60 (76.9)18 (23.1)Tumor localization\< 0.0010.02 central25 (47.2)28 (52.8)36 (66.7)18 (33.3) peripheral111 (74.5)38 (25.5)122 (81.9)27 (18.1)Tumor size0.0110.042 ≤ 3 cm77 (75.5)25 (24.5)86 (84.3)16 (15.7) \> 3 cm59 (57.8)43 (42.8)73 (71.6)29 (28.4)Lobe distribution0.9180.385 UL^a^85 (66.4)43 (33.6)97 (75.8)31 (24.2) Non-UL51 (67.1)25 (32.9)62 (81.6)14 (18.4)pT-category0.0150.081 pT170 (77.8)20 (22.2)77 (85.6)13 (14.4) pT233 (61.1)21 (38.9)40 (74.1)14 (25.9) pT318 (51.4)17 (48.6)23 (65.7)12 (34.3) pT413 (56.5)10 (43.5)17 (73.9)6 (26.1)R-classification0.0170.088 R0130 (68.8)59 (31.2)150 (79.4)39 (20.6) R1--25 (35.7)9 (64.3)8 (57.1)6 (42.9)L-status\< 0.001\< 0.001 L055 (96.5)2 (3.5)56 (98.2)1 (1.8) L180 (54.8)66 (45.2)102 (69.9)44 (30.1)V-status0.0060.004 V0117 (70.9)48 (29.1)135 (81.1)30 (18.2) V18 (47.4)20 (52.6)23 (60.5)15 (39.5)Pn-Status0.0880.34 Pn0131 (67.9)62 (32.1)149 (77.2)44 (22.8) Pn14 (40.0)6 (60.0)9 (90.0)1 (10.0)Histological tumor type0.2140.646 Adeno-Ca.^b^84 (71.8)33 (28.2)94 (80.3)23 (19.7)56 (74.4)19 (25.6) SCC^c^45 (60.0)30 (40.0)9 (75.0)3 (25.0) others7 (58.3)5 (41.7)Grading0.0160.001 G125 (89.3)3 (10.7)27 (96.4)1 (3.6) G264 (67.4)31 (32.6)79 (83.2)16 (16.8) G339 (57.4)29 (42.6)43 (63.2)25 (36.8) G47 (58.3)5 (41.7)9 (75.0)3 (25.0)^a^*UL* Upper lobe, ^b^*Adeno-Ca.* Adenocarcinoma, ^c^*SCC* Squamous cell carcinomaTable 3Univariate Analysis of positive lymph nodes (pN0, pN+)VariablespN0 (%)pN+ (%)*P*-ValueSex0.397 male85 (59.9)57 (40.1) female41 (66.1)21 (33.9)Age0.314 ≤ 68 years63 (58.3)45 (41.7) \> 68 years63 (65.6)33 (34.4)Tumor site0.067 Right84 (66.7)42 (33.3) Left42 (53.8)36 (46.2)Tumor localization\< 0.001 central22 (41.5)31 (58.5) peripheral104 (69.8)45 (30.2)Tumor size\< 0.001 ≤ 3 cm76 (74.5)26 (25.5) \> 3 cm50 (49)52 (51)Lobe distribution0.834 UL ^a^78 (60.9)50 (39.1) Non-UL40 (62.5)24 (37.5)Number of dissected LN ^b^0.005pT-category0.001 pT169 (76.7)21 (23.3) pT227 (50.9)26 (49.1) pT317 (47.2)19 (52.8) pT411 (47.8)12 (52.2)R-classification0.048 R0120 (96.0)5 (4.0) R1--269 (88.5)9 (11.5)L-status\< 0.001 L054 (94.7)3 (5.3) L171 (48.6)75 (51.4)V-status0.001 V0111 (67.3)54 (32.7) V114 (36.8)24 (63.2)Pn-status0.188 Pn0121 (96.8)4 (3.2) Pn172 (92.3)6 (7.7)Histological tumor type0.141 Adeno-Ca.^b^79 (67.5)38 (32.5) SCC^c^41 (54.7)34 (45.3) others6 (50.0)6 (50.0)Grading0.005 G122 (88.0)3 (12.0) G260 (63.2)35 (36.8) G334 (50.0)34 (50.0) G46 (50.0)6 (50.0)^a^*UL* Upper lobe, ^b^*Adeno-Ca.* Adenocarcinoma, ^c^*SCC* Squamous cell carcinoma
